KRAS and neoplasm: The induced genetic deletion of mutant KRAS in the murine NSCLC tumor model Kras+/FSFG12Vlox;Trp53F/F;Rosa26-CreERT2KI/KI;Tg.hUBC-CreERT2+/T caused rapid tumor regressions [39].